Drug Shortage Report for PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION
Report ID | 29438 |
Drug Identification Number | 02370174 |
Brand name | PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION |
Common or Proper name | PIPERACILLIN/TAZOBACTAM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
Strength(s) | 4G 0.5G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-11-16 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-10-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2018-10-11 | French | Compare |
v10 | 2018-10-11 | English | Compare |
v9 | 2018-03-07 | French | Compare |
v8 | 2018-03-07 | English | Compare |
v7 | 2018-03-07 | French | Compare |
v6 | 2018-03-07 | English | Compare |
v5 | 2018-01-03 | French | Compare |
v4 | 2018-01-03 | English | Compare |
v3 | 2017-11-17 | English | Compare |
v2 | 2017-11-16 | French | Compare |
v1 | 2017-11-16 | English | Compare |
Showing 1 to 11 of 11